News
12d
Zacks.com on MSNShould You Continue to Hold STERIS Stock in Your Portfolio Now?STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $265.8, along ...
Barchart on MSN6d
What to Expect From STERIS' Next Quarterly Earnings ReportSTERIS is set to report its second-quarter results next month, and analysts are projecting a double-digit rise in earnings.
Steris (STE) stock and Solventum (SOLV) stock is upgraded, while RxSight (RXST) stock is downgraded at Morgan Stanley on valuations. Read more here.
The medical device cleaning market is witnessing steady growth, driven by the increasing volume of surgical procedures and heightened awareness of infection control. Rising demand for sterilization ...
StockStory.org on MSN7d
Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified StocksThe end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Steris acquired two Coon Rapids medical office buildings for $13.1M, expanding its Twin Cities footprint.
The global operating room equipment market is set to witness a growth rate of 5% in the next 5 years. Technological ...
View the latest Steris PLC (STE) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Eugenic beliefs had serious implications for Latinos in California, especially working-class Mexican-origin women and men, who were a growing population in the state in the first half of the 20th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results